QuVa Pharma is a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. QuVa was purpose-built to change the 503B industry for the better and is leading the way in making it more safe, efficient, and reliable. With unmatched expertise in cGMPs and sterile pharmaceutical manufacturing, we achieve higher than required quality and safety standards and maintain a leading FDA compliance record, so hospitals can more confidently and reliably focus on patient care. While our leading cGMP processes, sterile-to-sterile portfolio, and expansive capacity of 340,000 sq ft across five facilities are the foundation of success, it is our transparency, customer-focused service, and contracted supply arrangements that enable us to help hospitals and health systems better meet their patient care and operational needs.
As FDA compliance becomes more stringent, QuVa's ability to reliably supply the highest-quality products is more valuable than ever and allows hospitals to spend more time on patient care and less time worried about beyond use dates, waste, workload inefficiencies, and compliance. That is why QuVa is proud to be recognized as the partner of choice for many of the nation’s leading health systems. So, whether you are calling for a response or being called on for a solution, know that QuVa is accountable, and in us, you always have an answer.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
1,001-5,000 employees
-
Headquarters
-
Sugar Land, Texas
-
Type
-
Privately Held
-
Founded
-
2015
-
Specialties
-
503B Compounding, 503B Outsourcing Services, Antibiotics, Anticoagulation, Antiemetic, Cardiovascular, Electrolyte Solutions, Emergency Department, Epidural, General Medicine, Labor & Delivery/OB, Local Anesthesia, OR Syringes, Pain Management, and Ketamine
